Mark Laughlin

3.2k total citations
33 papers, 2.4k citations indexed

About

Mark Laughlin is a scholar working on Infectious Diseases, Virology and Pharmacology. According to data from OpenAlex, Mark Laughlin has authored 33 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Virology and 8 papers in Pharmacology. Recurrent topics in Mark Laughlin's work include HIV Research and Treatment (10 papers), Antifungal resistance and susceptibility (7 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Mark Laughlin is often cited by papers focused on HIV Research and Treatment (10 papers), Antifungal resistance and susceptibility (7 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Mark Laughlin collaborates with scholars based in United States, Germany and Canada. Mark Laughlin's co-authors include Josephine Lim, Rachel Courtney, Francisco González‐Scarano, Janet M. Harouse, David Wexler, Elaine Radwanski, Steven L. Spitalnik, Donald H. Silberberg, Shama Bhat and Sudhakar M. Pai and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Mark Laughlin

33 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Laughlin United States	18	1.2k	934	731	447	397	33	2.4k
Yuji Iizawa Japan	23	621 0.5×	486 0.5×	652 0.9×	700 1.6×	211 0.5×	46	2.8k
John A. Bilello United States	27	604 0.5×	302 0.3×	583 0.8×	351 0.8×	181 0.5×	54	2.1k
Edward P. Garvey United States	39	1.9k 1.6×	1.3k 1.4×	655 0.9×	1.5k 3.4×	268 0.7×	82	5.1k
Andrea Savarino Italy	27	1.5k 1.2×	469 0.5×	729 1.0×	754 1.7×	109 0.3×	79	3.2k
Davide Zella United States	34	1.1k 0.9×	616 0.7×	426 0.6×	1.6k 3.6×	94 0.2×	96	4.0k
Helen C. Steel South Africa	27	494 0.4×	667 0.7×	166 0.2×	509 1.1×	112 0.3×	93	2.2k
Chuan Li China	29	980 0.8×	254 0.3×	396 0.5×	1.1k 2.5×	171 0.4×	132	3.5k
Sara Colombo Italy	32	1.1k 0.9×	379 0.4×	773 1.1×	1.8k 3.9×	194 0.5×	75	4.0k
Sergey N. Kochetkov Russia	27	794 0.6×	905 1.0×	290 0.4×	1.8k 3.9×	198 0.5×	255	3.5k
Sornchai Looareesuwan Thailand	46	568 0.5×	524 0.6×	163 0.2×	493 1.1×	123 0.3×	75	6.4k

Countries citing papers authored by Mark Laughlin

Since Specialization

Citations

This map shows the geographic impact of Mark Laughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Laughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Laughlin more than expected).

Fields of papers citing papers by Mark Laughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Laughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Laughlin. The network helps show where Mark Laughlin may publish in the future.

Co-authorship network of co-authors of Mark Laughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Laughlin. A scholar is included among the top collaborators of Mark Laughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Laughlin. Mark Laughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karadayian, Analía G., Mark Laughlin, & Renato Cutrera. (2012). Estrogen blocks the protective action of melatonin in a behavioral model of ethanol-induced hangover in mice. Physiology & Behavior. 107(2). 181–186. 13 indexed citations

Laughlin, Mark, et al.. (2010). Role of 11β-hydroxysteroid dehydrogenase 2 renal activity in potassium homeostasis in rats with chronic renal failure. Brazilian Journal of Medical and Biological Research. 43(1). 52–56. 1 indexed citations

Wilcock, Gordon, Sandra E. Black, Suzanne Hendrix, et al.. (2008). Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial. The Lancet Neurology. 7(6). 483–493. 204 indexed citations

Galasko, Douglas, N. R. Graff-Radford, Susanne May, et al.. (2007). Safety, Tolerability, Pharmacokinetics, and Aβ Levels After Short-term Administration of R-flurbiprofen in Healthy Elderly Individuals. Alzheimer Disease & Associated Disorders. 21(4). 292–299. 94 indexed citations

Wilcock, Gordon, Sandra E. Black, Suzanne Hendrix, et al.. (2006). O4–03–08: Efficacy and safety of MPC–7869 (R–flurbiprofen), a selective Aβ42–lowering agent, in Alzheimer's disease (AD): Results of a 12–month phase 2 trial and 1–year follow–on study. Alzheimer s & Dementia. 2(3S_Part_3). 15 indexed citations

Courtney, Ronan, Winter J. Smith, Paul Statkevich, et al.. (2005). Posaconazole Pharmacokinetics, Safety, and Tolerability in Subjects With Varying Degrees of Chronic Renal Disease. The Journal of Clinical Pharmacology. 45(2). 185–192. 94 indexed citations

Ezzet, Farkad, David Wexler, Rachel Courtney, et al.. (2005). Oral Bioavailability of Posaconazole in Fasted Healthy Subjects. Clinical Pharmacokinetics. 44(2). 211–220. 151 indexed citations

Wexler, David, Ronan Courtney, William O. Richards, et al.. (2004). Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study. European Journal of Pharmaceutical Sciences. 21(5). 645–653. 167 indexed citations

Courtney, Rachel, David Wexler, Elaine Radwanski, Josephine Lim, & Mark Laughlin. (2003). Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults. British Journal of Clinical Pharmacology. 57(2). 218–222. 267 indexed citations

10.

Kim, Hong, Mark Laughlin, Stephen R. Indelicato, et al.. (2003). Use of high-performance liquid chromatographic and microbiological analyses for evaluating the presence or absence of active metabolites of the antifungal posaconazole in human plasma. Journal of Chromatography A. 987(1-2). 243–248. 36 indexed citations

11.

Courtney, Rachel, Sudhakar M. Pai, Mark Laughlin, Josephine Lim, & Vijay Batra. (2003). Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults. Antimicrobial Agents and Chemotherapy. 47(9). 2788–2795. 244 indexed citations

12.

Kim, Hong, Chin‐Chung Lin, Mark Laughlin, et al.. (2000). Chiral high-performance liquid chromatographic analysis of antifungal SCH 56592 and evaluation of its chiral inversion in animals and humans. Chirality. 12(7). 590–597. 11 indexed citations

13.

Zhang, H, et al.. (1996). Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.. Proceedings of the National Academy of Sciences. 93(22). 12519–12524. 39 indexed citations

14.

Kolson, Dennis L., Ronald G. Collman, Renee Hrin, et al.. (1994). Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation. Journal of General Virology. 75(8). 1927–1934. 40 indexed citations

15.

Laughlin, Mark & Roger J. Pomerantz. (1994). Cellular Latency in HIV-1 Infection. Clinics in Laboratory Medicine. 14(2). 239–255. 3 indexed citations

16.

Laughlin, Mark, Steven L. Zeichner, Dennis L. Kolson, et al.. (1993). Sodium Butyrate Treatment of Cells Latently Infected with HIV-1 Results in the Expression of Unspliced Viral RNA. Virology. 196(2). 496–505. 61 indexed citations

17.

Harouse, Janet M., Shama Bhat, Steven L. Spitalnik, et al.. (1991). Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl Ceramide. Science. 253(5017). 320–323. 445 indexed citations

18.

Harouse, Janet M., et al.. (1989). Human choroid plexus cells can be latently infected with human immunodeficiency virus. Annals of Neurology. 25(4). 406–411. 50 indexed citations

19.

Harouse, Janet M., Mark Laughlin, James A. Hoxie, John Q. Trojanowski, & Francisco González‐Scarano. (1989). HIV Infection of Neural Cells. Annals of the New York Academy of Sciences. 567(1). 285–287. 1 indexed citations

20.

Younoszai, M. K., et al.. (1978). Maturation of Jejunum and Ileum in Rats. Journal of Clinical Investigation. 62(2). 271–280. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact